Why is Medico Remedies falling/rising?

As of 11-Aug, Medico Remedies Ltd's stock is currently priced at 38.90, reflecting a decrease of 0.37, or 0.94%. The stock has underperformed its sector by 1.85% today and has experienced a trend reversal, falling after two consecutive days of gains. It is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Additionally, investor participation has declined significantly, with delivery volume dropping by 64.24% compared to the 5-day average. Over the past week, the stock has decreased by 2.65%, and over the past month, it has fallen by 4.31%, while the year-to-date performance shows a substantial decline of 28.53%. Despite a healthy long-term growth outlook, with operating profit growing at an annual rate of 32.76% and a low Debt to EBITDA ratio of 0.94, the recent decrease in promoter confidence, as evidenced by a 1.2% reduction in their stake, may be contributing to the stock's downward movement. In the broader market context, Medico Remedies' short-term performance has been notably worse than the benchmark, with the Sensex only declining by 0.51% over the past week and 2.30% over the past month. This stark contrast highlights the stock's struggles relative to the overall market. While the company has shown positive financial results, including a 31.62% growth in PAT and a 24.19% increase in net sales, the declining promoter confidence could signal potential challenges ahead, leading investors to reassess their positions. The stock's performance over the past year, generating a return of 1.30%, is slightly better than the Sensex's return of 1.13%, but the significant year-to-date decline raises concerns about its future trajectory amidst the current market conditions.